Blood Filter Market Size & Share | Growth Forecast Report (2026-2035)

Blood Filter Market Overview

The Blood Filter Market size was estimated at about USD 4.31 billion in 2025 and is expected to reach around USD 4.76 billion in 2026, rising up to roughly USD 11.18 billion in 2035, growing at approximately 9.95% CAGR from 2026 to 2035.

Research Highlights

• Filtration kits and reagents held 36.20% in 2025 supported by broad use in blood processing and diagnostics.
• Infectious disease diagnostics accounted for 32.70% in 2025 due to continued blood borne infection testing.
• Clinical diagnostic laboratories represented 47.40% in 2025 owing to increasing diagnostic testing volumes.
• Genetic and molecular diagnostics are projected at approximately 8.60% CAGR because of expanding precision medicine applications.
• North America held 38.20% in 2025 supported by advanced healthcare infrastructure and established blood banking systems.

Market growth is attributed to the rising number of blood transfusions, the growing need for leukocyte reduced blood components, and an increase in the use of filtration-based transfusion technologies. Rising investments in blood banks and improvement in the quality control of blood products are some of the other factors driving the market across North America, Europe and the Asia Pacific region. The World Health Organization estimates 120.4 million blood donations made worldwide, and advocates for coordinated collection, processing, quality control and safe use of blood and blood components which propel the demand for blood filtration products.

Blood Filter Market Dynamics

Market Trends

The blood filter market comprises trends related to leukocyte reduction, improvement of fractionation precision and validation of blood purification processes. A major trend in the market is related to the increased use of pre-storage filtration in response to demands for improved safety and quality of blood transfusions. Another key trend is the use of novel approaches for producing specialized blood component filters that comply with the World Health Organization recommendations on standardized leukocyte reduction procedures and quality assurance in blood establishments.

Growth Drivers

The market is primarily driven by the growing demand for quality blood components and increasing numbers of blood transfusions. The rising use of leukocyte reduction technologies across blood banks and hospitals is also anticipated to propel the growth of the market. Moreover, the increasing global blood donation rates have also contributed to the growth of the market. According to World Health Organization reports on global blood donation statistics, 120.4 million blood donations were recorded worldwide. In addition, the focus on standardizing blood processing and transfusion practices across the globe is also driving the demand for blood filters.

Market Restraints/Challenges

Despite the high growth potential, the market is challenged by the need for process validation, quality assurance measures, and high costs associated with using specialized filtration equipment. In addition, blood filtration processes require standard operating procedures based on such factors as flow rates, temperature, and blood component properties. The World Health Organization recommends standardizing leukocyte reduction procedures and implementing quality control measures, which add complexity to the production of blood filters. These process requirements reduce the rate of adoption of blood filtration technologies by blood establishments and hospitals.

Market Opportunities

Some of the major opportunities in the market include the growing need for advanced leukocyte reduction and specialized blood component filtration. Advanced blood filtration products that offer dependable and validated approaches to leukocyte reduction and fractionation will provide significant opportunities to manufacturers, as hospitals and blood banks continue to adopt automated and standardized blood processing technologies. Another significant opportunity is the development of sustainable blood filtration products that minimize waste.

Global Blood Filter Market Report Coverage

Blood Filter Market Segmentation

By Product

Blood filter market from filtration kits, and reagents registered around 36.20% of the overall revenue share due to their wide range of applications in blood processing, diagnostic, and research.

Membranes, filters, and consumables, on the other hand, are anticipated to witness the highest growth rate of approximately 8.10% during 2026 to 2035. The rising demand for disposable and efficient filters with high biocompatibility is expected to propel the growth of this segment throughout the forecast period.

By Application

Infectious disease diagnostics accounted for around 32.70% of the overall blood filter market revenue in 2025. The high prevalence of infectious diseases across the globe along with the surging need for reliable and rapid diagnostic tests is anticipated to drive the growth of this segment during the forecast period.

Genetic and molecular diagnostics segment is expected to register the highest CAGR of approximately 8.60% during 2026 to 2035. This segment’s expansion is fueled by the growing applications of molecular diagnostic tests and the rising adoption of precision medicine.

By End Use

Clinical diagnostic laboratories contributed for around 47.40% of the overall revenue of the market. The increasing number of diagnostic tests coupled with the growing need for high-quality blood samples in the healthcare industry is likely to drive the growth of this segment.

On the other hand, hospitals and blood banks are expected to witness the highest growth rate of approximately 7.90% during 2026 to 2035. The rising need for blood transfusion and expansion of healthcare infrastructure worldwide are some of the key factors that would contribute to the growth of this segment.

Regional Insights

North America

North America held around 38.20% of the market in 2025. This was supported by the developed healthcare infrastructure, well-established blood banking and filtration networks, and high rates of adoption of filtration technologies. The growth is supported by the demand for blood transfusion services and the growing investment in blood processing technologies. The government backed healthcare systems and the regulatory environment promote the collection, processing, and transfusion of blood in a safe and standardized manner. Similarly, related blood processing research and development activities highlight North America as the key region with a major presence in the global market.

Asia Pacific

Asia Pacific accounted for around 27.40% of the global market in 2025. The region is witnessing a rise in healthcare infrastructure, blood transfusion needs, and investment in blood processing technologies. The region is projected to maintain its substantial share in the global market during the forecast period on the back of government led healthcare programs and initiatives to improve access to diagnostic and transfusion services. Blood filter research and related blood processing data point towards Asia Pacific being the key regional market for the coming years.

Europe

Europe accounted for around 20.10% share of the market share in 2025. The developed blood transfusion networks and the emphasis on quality assurance make the region one of the key players in the global market. The growth is backed by the modern healthcare infrastructure and a strong focus on blood safety. Blood collection, processing, and transfusion services in the European region operate under strict guidelines that encourage the adoption of standardized and advanced blood processing technologies.

Rest of the World

Rest of the World is estimated to account for around 7.60% of the market in 2025. Similar to other regions, the healthcare infrastructure and blood donation programs are being developed with an emphasis on increasing blood collection, distribution, and transfusion rates. The World Health Organization (WHO) has been leading the charge towards standardized and sustainable national blood systems and developing strategies for quality-assured transfusion services across the globe. The other 6.70% of the market is distributed among other smaller and developing regions.

Competitive Landscape / Company Insights

The blood filter market is moderately competitive where key players are focused on enhancing the filtration process, membrane technology, blood purification systems, and geographical presence. Moreover, the companies are also emphasizing adopting new technologies related to advanced filtration and blood processing to strengthen their position in the market. The World Health Organization has been focusing on the appropriate processing of blood and its subsequent transfusion. Also, major global players are enhancing their purification processes by launching new products and investing in research and development. Recently, Thermo Fisher Scientific acquired Solventum’s purification and filtration business that is anticipated to intensify the competition in the region.

Mini Profiles

Asahi Kasei Corporation focuses on blood purification and filtration technologies, supported by specialized medical products, membrane expertise and established healthcare capabilities across dialysis and blood treatment applications.

Baxter International operates across blood purification and renal care segments, emphasizing dialysis systems, filtration technologies and integrated treatment solutions for hospitals and specialized care settings.

Cerus Corporation leverages blood safety technologies and specialized blood component processing solutions, supported by its Helinx technology platform and focus on improving transfusion safety.

ExThera Medical focuses on extracorporeal blood purification technologies, supported by specialized filtration systems designed for removing targeted pathogens and inflammatory mediators from circulating blood.

Fresenius Medical Care provides blood purification and dialysis solutions, supported by extensive clinical expertise, established treatment infrastructure and technologies serving patients requiring renal replacement therapy.

Key Players

• Asahi Kasei Corporation
• Baxter International
• B. Braun
• Melsungen
• Cerus Corporation
• ExThera Medical
• Fresenius Medical Care
• Haemonetics Corporation
• Jafron Biomedical
• Nipro Corporation
• Thermo Fisher Scientific

Recent Developments

Nipro continued expanding its blood purification portfolio, with dialysis and filtration technologies remaining important components of its medical business. Its ongoing development of renal care equipment supports demand for advanced blood filtration systems across hospital and dialysis settings.

Jafron Biomedical continued strengthening its blood purification portfolio, including adsorption and extracorporeal blood treatment technologies. The company remains a recognized participant in the global blood filtration and purification market.

Toray continued developing membrane based medical technologies used in blood purification and dialysis applications. Its filtration expertise supports the company's position in advanced blood treatment systems and specialized medical membranes.

CytoSorbents continued commercial development of its extracorporeal blood purification technologies for removing inflammatory mediators and other substances from circulating blood. The company remains among the specialized players identified in blood purification market assessments.

Thermo Fisher Scientific continued expanding filtration, sample preparation and purification capabilities serving diagnostic and laboratory applications. Its broad portfolio supports growing demand for efficient blood sample processing and specialized filtration technologies.

Table of Contents for Blood Filter Market Report

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Product 
                  1.2.2.    By Application 
                  1.2.3.    By End Use 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2035

5.    Market Segmentation Estimate and Forecast

       5.1.    By Product 
                 5.1.1. Filtration Kits and Reagents
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2035
                 5.1.2. Membranes
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2035
                 5.1.3.  Filters and Consumables
                           5.1.3.1. Market Definition
                           5.1.3.2. Market Estimation and Forecast to 2035
                 5.1.4. Sample Preparation Systems
                           5.1.4.1. Market Definition
                           5.1.4.2. Market Estimation and Forecast to 2035
                 5.1.5. Specialty Assays and Columns
                           5.1.5.1. Market Definition
                           5.1.5.2. Market Estimation and Forecast to 2035

       5.2.    By Application 
                 5.2.1. Infectious Disease Diagnostics
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2035
                 5.2.2. Toxicology and Immunodiagnostics
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2035
                 5.2.3. Cancer Diagnostics
                           5.2.3.1. Market Definition
                           5.2.3.2. Market Estimation and Forecast to 2035
                 5.2.4. Genetic/Molecular Diagnostics
                           5.2.4.1. Market Definition
                           5.2.4.2. Market Estimation and Forecast to 2035
                 5.2.5. Others
                           5.2.5.1. Market Definition
                           5.2.5.2. Market Estimation and Forecast to 2035

       5.3.    By End Use 
                 5.3.1. Clinical Diagnostic Labs
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2035
                 5.3.2. Hospitals
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2035
                 5.3.3. Research and Academic Institutes
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2035
                 5.3.4. Others
                           5.3.4.1. Market Definition
                           5.3.4.2. Market Estimation and Forecast to 2035

6.   North America Market Estimate and Forecast

      6.1.    By Product   
      6.2.    By Application   
      6.3.    By End Use   
                6.3.1.     U.S. Market Estimate and Forecast
                6.3.2.     Canada Market Estimate and Forecast
                6.3.3.     Mexico Market Estimate and Forecast

7.   Europe Market Estimate and Forecast

      7.1.    By Product   
      7.2.    By Application   
      7.3.    By End Use   
                7.3.1.     Germany Market Estimate and Forecast
                7.3.2.     France Market Estimate and Forecast
                7.3.3.     U.K. Market Estimate and Forecast
                7.3.4.     Italy Market Estimate and Forecast
                7.3.5.     Spain Market Estimate and Forecast
                7.3.6.     Russia Market Estimate and Forecast
                7.3.7.     Rest of Europe Market Estimate and Forecast

8.   Asia-Pacific (APAC) Market Estimate and Forecast

      8.1.    By Product   
      8.2.    By Application   
      8.3.    By End Use   
                8.3.1.     China Market Estimate and Forecast
                8.3.2.     Japan Market Estimate and Forecast
                8.3.3.     India Market Estimate and Forecast
                8.3.4.     South Korea Market Estimate and Forecast
                8.3.5.     Rest of Asia-Pacific Market Estimate and Forecast

9.   Rest of the World (RoW) Market Estimate and Forecast

      9.1.    By Product   
      9.2.    By Application   
      9.3.    By End Use   
                9.3.1.     Brazil Market Estimate and Forecast
                9.3.2.     Saudi Arabia Market Estimate and Forecast
                9.3.3.     South Africa Market Estimate and Forecast
                9.3.4.     U.A.E. Market Estimate and Forecast
                9.3.5.     Other Countries Market Estimate and Forecast

10.  Company Profiles

       10.1.   Asahi Kasei Corporation
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.2.   Baxter International
                  10.2.1.    Snapshot
                  10.2.2.    Overview
                  10.2.3.    Offerings
                  10.2.4.    Financial Insight
                  10.2.5.    Recent Developments
       10.3.   B. Braun Melsungen
                  10.3.1.    Snapshot
                  10.3.2.    Overview
                  10.3.3.    Offerings
                  10.3.4.    Financial Insight
                  10.3.5.    Recent Developments
       10.4.   Cerus Corporation
                  10.4.1.    Snapshot
                  10.4.2.    Overview
                  10.4.3.    Offerings
                  10.4.4.    Financial Insight
                  10.4.5.    Recent Developments
       10.5.   ExThera Medical
                  10.5.1.    Snapshot
                  10.5.2.    Overview
                  10.5.3.    Offerings
                  10.5.4.    Financial Insight
                  10.5.5.    Recent Developments
       10.6.   Fresenius Medical Care
                  10.6.1.    Snapshot
                  10.6.2.    Overview
                  10.6.3.    Offerings
                  10.6.4.    Financial Insight
                  10.6.5.    Recent Developments
       10.7.   Haemonetics Corporation
                  10.7.1.    Snapshot
                  10.7.2.    Overview
                  10.7.3.    Offerings
                  10.7.4.    Financial Insight
                  10.7.5.    Recent Developments
       10.8.   Jafron Biomedical
                  10.8.1.    Snapshot
                  10.8.2.    Overview
                  10.8.3.    Offerings
                  10.8.4.    Financial Insight
                  10.8.5.    Recent Developments
       10.9.   Nipro Corporation
                  10.9.1.    Snapshot
                  10.9.2.    Overview
                  10.9.3.    Offerings
                  10.9.4.    Financial Insight
                  10.9.5.    Recent Developments
       10.10.   Thermo Fisher Scientific
                  10.10.1.    Snapshot
                  10.10.2.    Overview
                  10.10.3.    Offerings
                  10.10.4.    Financial Insight
                  10.10.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.